Get the Stockscreener App
1.72
1.71%
-0.03
Seer Inc stock is traded at $1.72, with a volume of 230.18K.
It is down -1.71% in the last 24 hours and down -12.24% over the past month.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
See More
Previous Close:
$1.75
Open:
$1.75
24h Volume:
230.18K
Relative Volume:
0.57
Market Cap:
$94.57M
Revenue:
$16.45M
Net Income/Loss:
$-73.60M
P/E Ratio:
-1.3443
EPS:
-1.2795
Net Cash Flow:
$-46.25M
1W Performance:
-8.02%
1M Performance:
-12.24%
6M Performance:
-14.00%
1Y Performance:
-17.31%
1-Day Range:
$1.71
$1.7507
1-Week Range:
$1.71
$1.895
52-Week Range:
$1.65
$2.41
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.72 | 96.22M | 16.45M | -73.60M | -46.25M | -1.2795 |
VRTX
Vertex Pharmaceuticals Inc
|
436.95 | 114.32B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
698.25 | 74.74B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
799.32 | 51.13B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
286.98 | 39.18B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
145.66 | 31.78B | 742.00K | -1.37B | -1.07B | -7.0731 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
Seer stock rises after investor group sweetens takeover bid - MSN
Seer (SEER) price target increased by 33.33% to 4.08 - MSN
Seer, Inc. (SEER) Reports Q2 Loss, Beats Revenue Estimates - MSN
Seer, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:SEER) 2026-05-16 - Seeking Alpha
Seer files patent infringement lawsuit against Nanomics Biotechnology - MSN
Seer reaffirms $16M-$18M 2026 revenue guidance amid new patent suit and commercial leadership hire - MSN
Seer (NASDAQ: SEER) Amendment: Farokhzad 6.92M shares, 12.0% ownership - Stock Titan
Seer, Inc. (NASDAQ:SEER) Q1 2026 Earnings Call Transcript - Insider Monkey
Seer Earnings Call Balances Near-Term Pain, Long-Term Promise - TipRanks
Seer (SEER) Shareholders Face New Acquisition Proposal Amid Disa - GuruFocus
Seer joins Thermo Fisher tools in large-scale proteomics effort - MSN
Seer (SEER) Stock Rises Over 7% Amid Acquisition Bid - GuruFocus
The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc. - Investing News Network
Seer (SEER) Shares Surge as Acquisition Offer Increases to $2.40 - GuruFocus
[DFAN14A] Seer, Inc. SEC Filing - Stock Titan
The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc - marketscreener.com
Radoff-JEC Group Raises Bid for Seer in Escalating Governance Fight - citybiz
Seer, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
The Radoff-JEC Group Submits Its Third Non-Binding Proposal To Acquire Seer, Inc. SEER - Moomoo
Canaccord reiterates Buy on Seer stock, cites long-term potential By Investing.com - Investing.com Nigeria
Canaccord reiterates Buy on Seer stock, cites long-term potential - Investing.com
Seer Inc (SEER) Q1 2026 Earnings Call Highlights: Navigating Rev - GuruFocus
Seer Q1 Earnings Call Highlights - inkl
Is Seer Inc (SEER) 27.8% Undervalued After Q1 2026 Earnings? EPS - GuruFocus
Transcript : Seer, Inc., Q1 2026 Earnings Call, May 13, 2026 - marketscreener.com
Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook - Investing News Network
SEER: Revenue fell in Q1 2026, but guidance was reaffirmed as cost discipline and innovation continued - TradingView
SEER: Revenue fell in Q1 2026, but guidance is reaffirmed as cost controls and new leadership support growth - TradingView
Earnings call transcript: Seer Inc. Q1 2026 beats EPS forecasts, stock rises - Investing.com Australia
Full Transcript: Seer Q1 2026 Earnings Call - Benzinga
Seer Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Seer (NASDAQ: SEER) Q1 2026 revenue drops as losses persist - Stock Titan
SEER: Revenue fell but net loss narrowed; Proteograph adoption and large-scale studies drive outlook - TradingView
Seer, Inc. 1Q 2026: Revenue $2.79M, EPS $(0.30) — 10-Q Summary - TradingView
Q1 2026 Seer Inc Earnings Call Transcript - GuruFocus
Seer (NASDAQ: SEER) Q1 2026 revenue drops 34% as loss narrows - Stock Titan
Seer, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
MSN Money - MSN
Seer files patent suit against Nanomics over protein tech - Investing.com UK
Seer files patent suit against Nanomics over protein tech By Investing.com - Investing.com Australia
SEER Sues Nanomics in U.S. District Court for Patent Infringement - geneonline.com
Seer Files Patent Infringement Lawsuit Against Nanomics - Yahoo Finance
Seer Q1 2026 Earnings Call Transcript - MarketBeat
Earnings To Watch: Seer Inc (SEER) Reports Q1 2026 Result - GuruFocus
Seer (SEER) grants CCO 75,000 RSUs and 225,000 stock options - Stock Titan
Seer (SEER) Chief Commercial Officer Anthony Bazarko files initial Form 3 - Stock Titan
TradingKey - TradingKey
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seer Inc Stock (SEER) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Farokhzad Omid | CEO AND CHAIR |
Feb 18 '26 |
Sale |
1.99 |
24,385 |
48,646 |
3,349,064 |
| Horn David R. | PRESIDENT & CFO |
Nov 19 '25 |
Sale |
1.97 |
6,797 |
13,400 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Nov 19 '25 |
Sale |
1.97 |
33,838 |
66,708 |
1,238,230 |
| Horn David R. | PRESIDENT & CFO |
Aug 20 '25 |
Sale |
2.04 |
6,827 |
13,955 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Aug 20 '25 |
Sale |
2.04 |
33,992 |
69,483 |
1,272,068 |
| Nishar Dipchand | Director |
Jun 13 '25 |
Sale |
2.08 |
30,253 |
62,935 |
49,204 |
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):